885266-93-3 Usage
General Description
2,5-Bis-(difluoromethoxy)-bromobenzene is a chemical compound with the molecular formula C8H6BrF4O2. It is a brominated aromatic compound that contains two difluoromethoxy groups. 2,5-Bis-(difluoromethoxy)-bromobenzene is primarily used in the field of organic synthesis and is a key building block for the synthesis of various pharmaceuticals, agrochemicals, and materials. Its unique structure and reactivity make it a valuable intermediate in the production of a wide range of complex organic compounds. It is also used as a research chemical in the study of organic reactions and mechanisms. Additionally, it may have potential applications in the development of new materials and technologies due to its specialized properties.
Check Digit Verification of cas no
The CAS Registry Mumber 885266-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,6 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885266-93:
(8*8)+(7*8)+(6*5)+(5*2)+(4*6)+(3*6)+(2*9)+(1*3)=223
223 % 10 = 3
So 885266-93-3 is a valid CAS Registry Number.
885266-93-3Relevant articles and documents
TETRAZOLE-SUBSTITUTED PYRAZOLOPYRIMIDINE INHIBITORS OF JAK KINASES AND USES THEREOF
-
Page/Page column 101, (2021/01/22)
Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof, that are useful as JAK kinase inhibitors are described herein. Also provided are pharmac
THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF
-
Paragraph 0332-0333, (2018/12/04)
Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.